| Gut microbiota linked to sexual preference and HIV infection M Noguera-Julian, M Rocafort, Y Guillén, J Rivera, M Casadellà, P Nowak, ... EBioMedicine 5, 135-146, 2016 | 402 | 2016 |
| Definition of the viral targets of protective HIV-1-specific T cell responses B Mothe, A Llano, J Ibarrondo, M Daniels, C Miranda, J Zamarreño, ... Journal of translational medicine 9, 1-20, 2011 | 188 | 2011 |
| High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control CT Berger, N Frahm, DA Price, B Mothe, M Ghebremichael, KL Hartman, ... Journal of virology 85 (18), 9334-9345, 2011 | 163 | 2011 |
| Cell cycle control and HIV-1 susceptibility are linked by CDK6-dependent CDK2 phosphorylation of SAMHD1 in myeloid and lymphoid cells E Pauls, A Ruiz, R Badia, M Permanyer, A Gubern, E Riveira-Muñoz, ... The Journal of Immunology 193 (4), 1988-1997, 2014 | 162 | 2014 |
| CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control B Mothe, A Llano, J Ibarrondo, J Zamarreno, M Schiaulini, C Miranda, ... PloS one 7 (1), e29717, 2012 | 158 | 2012 |
| A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques B Mothe, X Hu, A Llano, M Rosati, A Olvera, V Kulkarni, A Valentin, ... Journal of translational medicine 13, 1-23, 2015 | 103 | 2015 |
| Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection L Leal, AC Guardo, S Morón-López, M Salgado, B Mothe, C Heirman, ... Aids 32 (17), 2533-2545, 2018 | 86 | 2018 |
| HIVconsv vaccines and romidepsin in early-treated HIV-1-infected individuals: safety, immunogenicity and effect on the viral reservoir (Study BCN02) B Mothe, M Rosás-Umbert, P Coll, C Manzardo, MC Puertas, ... Frontiers in immunology 11, 823, 2020 | 78 | 2020 |
| Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1 B Mothe, N Climent, M Plana, M Rosàs, JL Jiménez, ... Journal of Antimicrobial Chemotherapy 70 (6), 1833-1842, 2015 | 72 | 2015 |
| Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection Y Guillén, M Noguera-Julian, J Rivera, M Casadellà, AS Zevin, M Rocafort, ... Mucosal immunology 12 (1), 232-246, 2019 | 70 | 2019 |
| Defining the HLA class I‐associated viral antigen repertoire from HIV‐1‐infected human cells N Ternette, H Yang, T Partridge, A Llano, S Cedeño, R Fischer, ... European journal of immunology 46 (1), 60-69, 2016 | 70 | 2016 |
| Altered response hierarchy and increased T-cell breadth upon HIV-1 conserved element DNA vaccination in macaques V Kulkarni, A Valentin, M Rosati, C Alicea, AK Singh, R Jalah, ... PloS one 9 (1), e86254, 2014 | 64 | 2014 |
| Therapeutic vaccination refocuses T-cell responses towards conserved regions of HIV-1 in early treated individuals (BCN 01 study) B Mothe, C Manzardo, A Sanchez-Bernabeu, P Coll, S Morón-López, ... EClinicalMedicine 11, 65-80, 2019 | 62 | 2019 |
| HIV-1 p24gag Derived Conserved Element DNA Vaccine Increases the Breadth of Immune Response in Mice V Kulkarni, M Rosati, A Valentin, B Ganneru, AK Singh, J Yan, M Rolland, ... PloS one 8 (3), e60245, 2013 | 59 | 2013 |
| Virological, immune and host genetics markers in the control of HIV infection B Mothe, J Ibarrondo, A Llano, C Brander Disease markers 27 (3-4), 105-120, 2009 | 59 | 2009 |
| Identification of effective subdominant anti-HIV-1 CD8+ T cells within entire post-infection and post-vaccination immune responses G Hancock, H Yang, E Yorke, E Wainwright, V Bourne, A Frisbee, ... PLoS pathogens 11 (2), e1004658, 2015 | 58 | 2015 |
| Contribution of immunological and virological factors to extremely severe primary HIV type 1 infection J Dalmau, MC Puertas, M Azuara, A Marino, N Frahm, B Mothe, NI Useros, ... Clinical infectious diseases 48 (2), 229-238, 2009 | 55 | 2009 |
| Efficacy, safety, and immunogenicity of a booster regimen of Ad26. COV2. S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled … K Hardt, A Vandebosch, J Sadoff, M Le Gars, C Truyers, D Lowson, ... The Lancet Infectious Diseases 22 (12), 1703-1715, 2022 | 53 | 2022 |
| Direct interrogation of viral peptides presented by the class I HLA of HIV-infected T cells JC Yaciuk, M Skaley, W Bardet, F Schafer, D Mojsilovic, S Cate, ... Journal of virology 88 (22), 12992-13004, 2014 | 53 | 2014 |
| Psychological stress is associated with high levels of IL-6 in HIV-1 infected individuals on effective combined antiretroviral treatment CR Fumaz, M Gonzalez-Garcia, X Borras, JA Muñoz-Moreno, ... Brain, behavior, and immunity 26 (4), 568-572, 2012 | 53 | 2012 |
